Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday’s Mid-Day Session
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,700 Today
CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.72% on an annualized basis producing an average annual return of 10.52%. Currently, CVS Health has a market capitalization of $131.99 billion.
Analyzing CVS Health’s Short Interest
CVS Health's (NYSE:CVS) short percent of float has risen 6.8% since its last report. The company recently reported that it has 14.38 million shares sold short, which is 1.1% of all regular shares that are available for trading.
As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
The FDA authorized an additional five batches of Moderna Inc’s (NASDAQ:MRNA) updated Covid booster shots made at Catalent Inc‘s (NYSE:CTLT) Indiana facility after…
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
The White House announced $1.5 billion in funding to tackle opioid overdoses, sanctions against traffickers, and increased funding for law…
$100 Invested In This Stock 20 Years Ago Would Be Worth $700 Today
CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.54% on an annualized basis producing an average annual return of 10.51%. Currently, CVS Health has a market capitalization of $132.71 billion.
Neptune Wellness Tweets ‘Forest Remedies is now available on http://CVS.com and at select CVS locations nationwide. We’re excited to be making plant-based wellness more accessible!!! ‘
https://twitter.com/Neptune_corp/status/1567881837179211783
Endexx Acquires Controlling Interest In Non-Nicotine Vape Producer Hyla
Endexx Corporation (OTCPK:EDXC) acquired a controlling interest in Hyla US Holdco Limited, a producer and distributor of organic, plant-based, all-natural, zero-nicotine vape products.
The acquisition provides two key benefits to Endexx in the near term: